Ex-Sanofi chief Olivier Brandicourt, current Blackstone advisor, jumps on Alnylam board

Former Sanofi chief Olivier Brandicourt, who departed his post with an unexpected early retirement last year, has made his move — as most C-suite executives inevitably do — to become a director on the board of a biopharma company.